By “reverse engineering” ketamine, Weill Cornell investigators have identified a specific opioid receptor pathway and a unique receptor “cross-talk” that drives rapid antidepressant effects.
Read more at Cerebratech
Read more at Cerebratech
Read more at Cerebratech
